Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence

Published:2021-11 Issue: Volume:143 Page:209-214
ISSN:0022-3956
Container-title:Journal of Psychiatric Research
language:en
Short-container-title:Journal of Psychiatric Research

Author:

Di Vincenzo Joshua D.,Lipsitz Orly^ORCID,Rodrigues Nelson B.,Lee Yena,Gill Hartej^ORCID,Kratiuk Kevin,Subramaniapillai Mehala,Mansur Rodrigo,McIntyre Roger S.,Rosenblat Joshua D.

Funder

H. Lundbeck A/S

Canadian Cancer Society

Bausch Health

National Natural Science Foundation of China

Sunovion

Canadian Institutes of Health Research

Novo Nordisk

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference24 articles.

1. Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation;Cusin;Aust. N. Z. J. Psychiatr.,2017

2. Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial;Daly;JAMA Psychiatry,2018

3. Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial;Daly;JAMA Psychiatry,2019

4. What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression;Gaynes;Psychiatr. Serv.,2009

5. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support;Harris;J. Biomed. Inf.,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of intravenous esketamine in reducing suicidal ideation and major depressive symptoms: A real-world evidence study;Journal of Affective Disorders Reports;2024-07

2. Ketamine in neuropsychiatric disorders: an update;Neuropsychopharmacology;2023-06-20

3. Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth;Journal of Psychopharmacology;2023-05-16

4. Replication of distinct trajectories of antidepressant response to intravenous ketamine;Journal of Affective Disorders;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3